Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

NPJ vaccines

Showing results (1-10 of 1,501) with videos related to

Pageof 151
Sort By:
NPJ Vaccines|March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory diseaseJoan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
NPJ Vaccines|December 4, 2021
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challengeClement A Meseda, Charles B Stauft, Prabhuanand Selvaraj, et al.
NPJ Vaccines|February 19, 2019
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal <i>Bacillus</i> <i>anthracis</i> spore inhalation challengeGenevieve M Weir, Lisa D MacDonald, Rajkannan Rajagopalan, et al.
NPJ Vaccines|February 19, 2019
Turning the corner on therapeutic cancer vaccinesRobert E Hollingsworth, Kathrin Jansen
NPJ Vaccines|April 3, 2019
Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigenShengtao Fan, Yun Liao, Yaru Lian, et al.
NPJ Vaccines|January 30, 2021
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccineSarah M Baker, Erik W Settles, Christopher Davitt, et al.
NPJ Vaccines|January 22, 2021
An epitope-based malaria vaccine targeting the junctional region of circumsporozoite proteinLucie Jelínková, Hugo Jhun, Allison Eaton, et al.
NPJ Vaccines|January 15, 2022
Preimmunization correlates of protection shared across malaria vaccine trials in adultsMaxwell L Neal, Fergal J Duffy, Ying Du, et al.
NPJ Vaccines|December 11, 2021
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccinesChakkumkal Anish, Michel Beurret, Jan Poolman
NPJ Vaccines|January 11, 2022
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studiesChangyoun Kim, Armine Hovakimyan, Karen Zagorski, et al.
Pageof 151

Showing results (1-10 of 1,501) with videos related to

Sort By:
Pageof 151
NPJ Vaccines|March 20, 2021
Ad26.COV2.S protects Syrian hamsters against G614 spike variant SARS-CoV-2 and does not enhance respiratory diseaseJoan E M van der Lubbe, Sietske K Rosendahl Huber, Aneesh Vijayan, et al.
NPJ Vaccines|December 4, 2021
MVA vector expression of SARS-CoV-2 spike protein and protection of adult Syrian hamsters against SARS-CoV-2 challengeClement A Meseda, Charles B Stauft, Prabhuanand Selvaraj, et al.
NPJ Vaccines|February 19, 2019
Single dose of DPX-rPA, an enhanced-delivery anthrax vaccine formulation, protects against a lethal <i>Bacillus</i> <i>anthracis</i> spore inhalation challengeGenevieve M Weir, Lisa D MacDonald, Rajkannan Rajagopalan, et al.
NPJ Vaccines|February 19, 2019
Turning the corner on therapeutic cancer vaccinesRobert E Hollingsworth, Kathrin Jansen
NPJ Vaccines|April 3, 2019
Role of innate lymphoid cells and dendritic cells in intradermal immunization of the enterovirus antigenShengtao Fan, Yun Liao, Yaru Lian, et al.
NPJ Vaccines|January 30, 2021
Burkholderia pseudomallei OMVs derived from infection mimicking conditions elicit similar protection to a live-attenuated vaccineSarah M Baker, Erik W Settles, Christopher Davitt, et al.
NPJ Vaccines|January 22, 2021
An epitope-based malaria vaccine targeting the junctional region of circumsporozoite proteinLucie Jelínková, Hugo Jhun, Allison Eaton, et al.
NPJ Vaccines|January 15, 2022
Preimmunization correlates of protection shared across malaria vaccine trials in adultsMaxwell L Neal, Fergal J Duffy, Ying Du, et al.
NPJ Vaccines|December 11, 2021
Combined effects of glycan chain length and linkage type on the immunogenicity of glycoconjugate vaccinesChakkumkal Anish, Michel Beurret, Jan Poolman
NPJ Vaccines|January 11, 2022
Efficacy and immunogenicity of MultiTEP-based DNA vaccines targeting human α-synuclein: prelude for IND enabling studiesChangyoun Kim, Armine Hovakimyan, Karen Zagorski, et al.
Pageof 151